Is Meribel Pharma Pessac FDA approved?

Meribel Pharma Pessac holds 1 FDA-registered establishment in France. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.

Where are Meribel Pharma Pessac's drugs manufactured?

The FDA register lists Pessac. Registered operations: analytical testing, labelling, finished drug manufacture, packaging.

What drugs does Meribel Pharma Pessac make?

8 products are listed under Meribel Pharma Pessac in the openFDA NDC Directory, most often as for suspension, extended release; pellets, coated, extended release; pellet. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Meribel Pharma Pessac

Data as of 24 Sept 2026 · How to read this entry

Request a quote Claim this profile

Registered sites: 1
Active NDC listings: 8
Live patents: 0
Countries: 1
Base: France

Authorisation

Registered operations

Analytical testing1Labelling1Finished drug manufacture1Packaging1

Sites

Registered establishments

Establishment	Address	Registered for	FEI / DUNS
Meribel Pharma Pessac	11 Avenue Gustave Eiffel, Pessac, 33660, France (FRA)	Analytical testing, Labelling, Finished drug manufacture, Packaging	3011269473266640441

Catalogue

Drug listings by form and route

8 active NDC listings: 8 drug for further processing. By marketing category: DRUG FOR FURTHER PROCESSING 8.

Dosage form	NDCs
for suspension, extended release	4
pellets, coated, extended release	2
pellet	1
tablet, delayed release particles	1

Route	NDCs

Labeller name on the listing	NDCs
meribel pharma pessac	8

Catalogue

Marketed products

Brand	Generic name	Form / route	NDC
-	CRIIa	pellets, coated, extended release	82646-002DRUG FOR FURTHER PROCESSING
-	CRIIc	pellets, coated, extended release	82646-003DRUG FOR FURTHER PROCESSING
-	IR Microparticles	pellet	82646-001DRUG FOR FURTHER PROCESSING
-	Omeprazole FCMT	tablet, delayed release particles	82646-004DRUG FOR FURTHER PROCESSING
-	Sodium Oxybate	for suspension, extended release	82646-006DRUG FOR FURTHER PROCESSING
-	sodium oxybate	for suspension, extended release	82646-005DRUG FOR FURTHER PROCESSING
-	sodium oxybate	for suspension, extended release	82646-007DRUG FOR FURTHER PROCESSING
-	sodium oxybate	for suspension, extended release	82646-008DRUG FOR FURTHER PROCESSING

Compare

Comparable companies in France

Parfums Christian Dior1 site · 224 NDC
Sevene SAS1 site · 154 NDC
BCM Cosmetique1 site · 72 NDC
Recordati Rare Diseases1 site · 21 NDC
Guerlain1 site · 18 NDC
OPELLA HEALTHCARE INTERNATIONAL SAS1 site · 17 NDC
Valdepharm1 site · 17 NDC
Septodont SAS1 site · 15 NDC
Laboratoires Clarins1 site · 14 NDC
C.F.E.B. - Sisley1 site · 7 NDC

Enquiry

Common questions

Is Meribel Pharma Pessac FDA approved?: Meribel Pharma Pessac holds 1 FDA-registered establishment in France. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are Meribel Pharma Pessac's drugs manufactured?: The FDA register lists Pessac. Registered operations: analytical testing, labelling, finished drug manufacture, packaging.
What drugs does Meribel Pharma Pessac make?: 8 products are listed under Meribel Pharma Pessac in the openFDA NDC Directory, most often as for suspension, extended release; pellets, coated, extended release; pellet. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.